AWR vs HTO

AWR exhibits stable financial health with a Piotroski F-Score of 6/9, indicating moderate strength, though the absence of an Altman Z-Score limits distress risk assessment. The stock appears fairly valued with a current price of $73.16 near the analyst target of $81.00 and intrinsic value estimate of $81.76, despite trading above the conservative Graham Number of $44.06. Solid profitability metrics—such as a 33.96% operating margin and 13.78% ROE—contrast with a bearish technical trend and weak insider sentiment. Revenue and earnings growth remain positive year-over-year, but recent quarterly volatility and limited analyst coverage warrant caution.

HTO presents a concerning divergence between its market price and fundamental performance. While the Piotroski F-Score of 6/9 indicates stable financial health, the company is suffering from severe growth decay with YoY earnings plummeting by 34.40% and revenue contracting. The stock is currently trading near its 52-week high ($59.67) despite being significantly overvalued relative to its intrinsic value ($20.44) and slightly above its Graham Number ($52.94). With bearish insider sentiment and poor liquidity ratios, the current valuation appears unsustainable.